Company profile
BIOADAPTIVES, INC. CIK 1575142
Ticker
BDPT (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Las Vegas, NV 89128
Fiscal year end
2025 (FY)
Key Financials
Revenue
$18.3K
Net income
-$1.56M
Total assets
$225.9K
Total liabilities
$2.36M
Stockholders' equity
-$2.13M
Cash & equivalents
$215.2K
Operating income
-$1.04M
Operating cash flow
-$516.0K
Capital expenditures
$18.0K
Fiscal year 2025, via 10-K filed 2026-04-14. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-5,701.8%
Net margin
-8,523.4%
Free cash flow
-$534.0K
Free cash flow margin
-2,921.7%
Liabilities / assets
1,042.9%
Equity / assets
-942.9%
CapEx / revenue
98.5%
Operating cash flow / net income
0.33×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$18.3K
-$1.56M
$225.9K
$2.36M
-$2.13M
2024
$12.7K
-$899.2K
$261.9K
$1.73M
-$1.46M
2023
$28.6K
-$712.5K
$104.0K
$1.75M
-$1.65M
2022
$17.2K
-$895.6K
$37.3K
$1.49M
-$1.45M
2021
$19.8K
-$1.05M
$148.6K
$1.24M
-$1.09M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-03
Financials filed via
Form 10-K
filed 2026-04-14
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Las Vegas, NV 89128
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:38 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.